- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05987982
Mouth Odor on Preventing Pneumonia by Oral Frailty
July 20, 2024 updated by: Chen, Yen-Chin, National Cheng-Kung University Hospital
Mouth Odor as a Precision Care Indicator for Preventing Pneumonia Among Middle-aged and Older Adults With Oral Frailty
This research plan aims to first collect data on the oral function and oral hygiene status of the elderly population in the community and to understand the normal model of oral frailty among the older adults in the community.
Subsequently, a comparison will be made between the oral status of hospitalized patients and the community-dwelling elderly population.
The goal is to verify whether oral odor can be used as an objective biological indicator following intervention.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The first stage will aim to examine the relationships between the level of oral frailty and pneumonia-associated pathogens, as well as to establish a mouth odor database among community-dwelling people; The second stage will compare the differences of the level of oral frailty, pneumonia associated pathogens, and mouth odor between 144 middle-aged and older healthy people and 160 hospitalization patients.
The third stage will confirm whether the mouth odor is an effective biological maker to show the changes of oral frailty, pneumonia-associated pathogens, and mouth odor after oral management rehabilitation.
Study Type
Interventional
Enrollment (Estimated)
304
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yen-Chin Chen
- Phone Number: 2019 +886-6-2353535
- Email: yenchin2427@gmail.com
Study Locations
-
-
-
Tainan City, Taiwan, 704
- Recruiting
- National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University
-
Contact:
- YenChin Chen
- Phone Number: 2019 +886-6-2353535
- Email: yenchin2427@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age ≥ 50 years old,
- Alert and oriented,
- With sufficient comprehension and cooperation,
- Willing to participate in oral assessment.
Exclusion Criteria:
- Patients who score below 5 on the General Practitioner Assessment of Cognition (GPCOG),
- Patients with oral treatments such as oral cancer treatment,
- Patients with oral treatments such as periodontal disease treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group with oral care
The investigators taught and monitored patients or caregivers to do oral care after meals and before sleep.
|
The patients will be required to maintain oral hygiene twice a day.
The investigators will assess their oral frailty, oral bacteria, oral odor, and other related clinical care data on the following time points: day 1 of hospitalization, day 3 of hospitalization, the day of discharge, one week after discharge, and one month after discharge.
|
|
Experimental: Group with oral management
The investigators taught and monitored patients or caregivers to oral health care plus oral exercises such as salivary glands massage methods after meals and before sleep.
|
The patients will be required to perform oral exercises and maintain oral hygiene twice a day.
The investigators will assess their oral frailty, oral bacteria, oral odor, and other related clinical care data on the following time points: day 1 of hospitalization, day 3 of hospitalization, the day of discharge, one week after discharge, and one month after discharge.
|
|
No Intervention: Group with standard of care
Only provided oral care education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clearance of pneumonia associated oral bacteria
Time Frame: The first day of admission (baseline)
|
The investigators collected tongue specimens from participants for bacterial isolation and identification.
The participants' specimens were collected using an eswab and sent for bacterial culture within 2 hours.
Bacterial colonies were quantified (CFU/ml).
To observe the variation caused by the number of bacteria, measurements were taken again after the intervention.
The investigators assessed the clearance of bacteria based on the baseline.
|
The first day of admission (baseline)
|
|
Clearance of pneumonia associated oral bacteria
Time Frame: Day 3 of admission
|
The investigators collected tongue specimens from participants for bacterial isolation and identification.
The participants' specimens were collected using an eswab and sent for bacterial culture within 2 hours.
Bacterial colonies were quantified (CFU/ml).
To observe the variation caused by the number of bacteria, measurements were taken again after the intervention.
The investigators assessed the clearance of bacteria based on the baseline.
|
Day 3 of admission
|
|
Clearance of pneumonia associated oral bacteria
Time Frame: Discharge day
|
The investigators collected tongue specimens from participants for bacterial isolation and identification.
The participants' specimens were collected using an eswab and sent for bacterial culture within 2 hours.
Bacterial colonies were quantified (CFU/ml).
To observe the variation caused by the number of bacteria, measurements were taken again after the intervention.
The investigators assessed the clearance of bacteria based on the baseline.
|
Discharge day
|
|
Clearance of pneumonia associated oral bacteria
Time Frame: 1-week after discharge day
|
The investigators collected tongue specimens from participants for bacterial isolation and identification.
The participants' specimens were collected using an eswab and sent for bacterial culture within 2 hours.
Bacterial colonies were quantified (CFU/ml).
To observe the variation caused by the number of bacteria, measurements were taken again after the intervention.
The investigators assessed the clearance of bacteria based on the baseline.
|
1-week after discharge day
|
|
Clearance of pneumonia associated oral bacteria
Time Frame: 1-month after discharge day
|
The investigators collected tongue specimens from participants for bacterial isolation and identification.
The participants' specimens were collected using an eswab and sent for bacterial culture within 2 hours.
Bacterial colonies were quantified (CFU/ml).
To observe the variation caused by the number of bacteria, measurements were taken again after the intervention.
The investigators assessed the clearance of bacteria based on the baseline.
|
1-month after discharge day
|
|
oral frailty measures (oral functions)
Time Frame: The first day of admission (baseline)
|
The investigators measured seven items for patients to identify oral frailty including 1) the number of teeth, 2) masticatory ability, 3) difficulty making the "ta" sound, 4) tongue pressure, 5) abnormal swallowing pressure, and 6) tongue coating index (TCI), 7) oral dryness.
Oral frailty was determined into three groups: non-oral frailty, 0 points; pre-oral frailty, 1-2 points; and oral frailty, ≥ 3 points.
|
The first day of admission (baseline)
|
|
oral frailty measures (oral functions)
Time Frame: Day 3 of admission
|
The investigators measured seven items for patients to identify oral frailty including 1) the number of teeth, 2) masticatory ability, 3) difficulty making the "ta" sound, 4) tongue pressure, 5) abnormal swallowing pressure, and 6) tongue coating index (TCI), 7) oral dryness.
Oral frailty was determined into three groups: non-oral frailty, 0 points; pre-oral frailty, 1-2 points; and oral frailty, ≥ 3 points.
|
Day 3 of admission
|
|
oral frailty measures (oral functions)
Time Frame: Discharge day
|
The investigators measured seven items for patients to identify oral frailty including 1) the number of teeth, 2) masticatory ability, 3) difficulty making the "ta" sound, 4) tongue pressure, 5) abnormal swallowing pressure, and 6) tongue coating index (TCI), 7) oral dryness.
Oral frailty was determined into three groups: non-oral frailty, 0 points; pre-oral frailty, 1-2 points; and oral frailty, ≥ 3 points.
|
Discharge day
|
|
oral frailty measures (oral functions)
Time Frame: 1-week after discharge day
|
The investigators measured seven items for patients to identify oral frailty including 1) the number of teeth, 2) masticatory ability, 3) difficulty making the "ta" sound, 4) tongue pressure, 5) abnormal swallowing pressure, and 6) tongue coating index (TCI), 7) oral dryness.
Oral frailty was determined into three groups: non-oral frailty, 0 points; pre-oral frailty, 1-2 points; and oral frailty, ≥ 3 points.
|
1-week after discharge day
|
|
oral frailty measures (oral functions)
Time Frame: 1-month after discharge day
|
The investigators measured seven items for patients to identify oral frailty including 1) the number of teeth, 2) masticatory ability, 3) difficulty making the "ta" sound, 4) tongue pressure, 5) abnormal swallowing pressure, and 6) tongue coating index (TCI), 7) oral dryness.
Oral frailty was determined into three groups: non-oral frailty, 0 points; pre-oral frailty, 1-2 points; and oral frailty, ≥ 3 points.
|
1-month after discharge day
|
|
Oral odor
Time Frame: The first day of admission (baseline)
|
A participant was requested to exhale two gas sampling gas for testing.
The investigators uesd an E-nose to identify the participants' odor.
To assess the variation of oral odor after different interventions.
|
The first day of admission (baseline)
|
|
Oral odor
Time Frame: Day 3 of admission
|
A participant was requested to exhale two gas sampling gas for testing.
The investigators uesd an E-nose to identify the participants' odor.
To assess the variation of oral odor after different interventions.
|
Day 3 of admission
|
|
Oral odor
Time Frame: Discharge day
|
A participant was requested to exhale two gas sampling gas for testing.
The investigators uesd an E-nose to identify the participants' odor.
To assess the variation of oral odor after different interventions.
|
Discharge day
|
|
Oral odor
Time Frame: 1-week after discharge day
|
A participant was requested to exhale two gas sampling gas for testing.
The investigators uesd an E-nose to identify the participants' odor.
To assess the variation of oral odor after different interventions.
|
1-week after discharge day
|
|
Oral odor
Time Frame: 1-month after discharge day
|
A participant was requested to exhale two gas sampling gas for testing.
The investigators uesd an E-nose to identify the participants' odor.
To assess the variation of oral odor after different interventions.
|
1-month after discharge day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 14, 2023
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
July 18, 2023
First Submitted That Met QC Criteria
August 4, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Actual)
July 23, 2024
Last Update Submitted That Met QC Criteria
July 20, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-ER-111-452
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
Clinical Trials on Oral exercises and oral hygiene
-
University of Mississippi Medical CenterCompletedEsophageal Cancer | Lung CancerUnited States
-
Addis Ababa UniversityCompletedStroke | Aspiration PneumoniaEthiopia
-
Wake Forest University Health SciencesCompletedHead and Neck Cancer | Radiation Toxicity | Radiation-Induced Xerostomia | Oral Complications of Chemotherapy and Head/Neck RadiationUnited States
-
Oelisoa AndriankajaNot yet recruitingObesity | Dental Care for ChildrenUnited States
-
Chang Gung Memorial HospitalEnrolling by invitationQuality of Life | Oral Hygiene | Sleep Quality | Oral Health Care | Noninvasive VentilatorsTaiwan
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyCompletedPlaque-Induced GingivitisTurkey (Türkiye)
-
Ankara UniversityCompletedOral Hygiene Education | Oral Hygiene Education MethodsTurkey
-
Gulf Medical UniversityNot yet recruitingGingivitis | Orthodontic TreatmentUnited Arab Emirates
-
University of California, IrvineLivionex IncCompletedPeriodontitis | Gingivitis | Dental PlaqueUnited States
-
University of WashingtonColgate PalmoliveCompleted